483 Hisun Pharmaceutical Hangzhou Apr 2014

483 Hisun Pharmaceutical Hangzhou Apr 2014

David Gomes FDA, Edmund Mrak FDA$119.00 - Available Now

FDA investigators audited the Hisun Pharmaceutical Hangzhou - Hangzhou, China facility and issued inspectional observations (via FDA 483) on 11 Apr 2014.

Product details

  • Category: Human Drugs
  • Inspection end: 11 Apr 2014
  • Location: Hangzhou, China
  • FEI: 3008481334
Add To Cart